Skip to main content
Veterinary Medicines

TETANUSAN 50 % oldatos injekció A.U.V.

Authorised
  • Magnesium chloride hexahydrate
  • Calcium gluconate
  • Sodium glycerophosphate pentahydrate

Product identification

Medicine name:
TETANUSAN 50 % oldatos injekció A.U.V.
Active substance:
  • Magnesium chloride hexahydrate
  • Calcium gluconate
  • Sodium glycerophosphate pentahydrate
Target species:
  • Cattle
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Magnesium chloride hexahydrate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    440.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium glycerophosphate pentahydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Kon-Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 5/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 5/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."